Seeking Alpha

Endo Pharmaceuticals (ENDP -1.4%) slips on a downgrade to Hold at Cantor earlier today, citing a...

Endo Pharmaceuticals (ENDP -1.4%) slips on a downgrade to Hold at Cantor earlier today, citing a mediocre Q1 and saying it sees no reason to buy the stock ahead of the the pending Lidoderm settlement.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)